Ameliorative potential of gallic acid on the activation of ros and down-regulation of antioxidant enzymes in cardiac tissue of rats infused with advanced glycation end products

Journal of Applied Pharmaceutical Science

Volumn 1, Issue 7, 2011, Pages 189-193

  Umadevi, S ^a   Gopi, V ^a   Parthasarathy, A ^a   Elangovan, V ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Advanced glycation end products; Antioxidant enzymes; Gallic acid; Oxidative stress

Indexed keywords

EID: 84875905538     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ahmed N, Advanced glycation endproducts--role in pathology of diabetic complications. Diabetes Res Clin Pract 2005; 1: 3-21.
2. Ajmani P, Yadav HN, Singh M, Sharma PL. Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovasc Disord 2011; 12;11:43.
3. Andreea SI, Marieta C, Anca D. AGEs and glucose levels modulate type I and III procollagen mRNA synthesis in dermal fibroblasts cells culture. Exp Diabetes Res. 2008; 2008: 473603.
4. Babu PV, Sabitha KE, Srinivasan P, Shyamaladevi CS. Green tea attenuates diabetes induced Maillard-type fluorescence and collagencross-linking in the heart of streptozotocin diabetic rats. Pharmacol Res 2007; 55:433-40.
5. Battiprolu PK, Gillette TG, Wang ZV, Lavandero S, Hill JA. Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets. Drug Discov Today Dis Mech 2010 7:135-143
6. Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, Tan AL, Fukami K, Thallas-Bonke V, Nawroth PP, Brownlee M, Bierhaus A, Cooper ME, Forbes JM. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol. 2009 20:742-52.
7. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82: 70-77.
8. Hartog JW, Voors AA, Bakker SJ, Smit AJ, van Veldhuisen DJ. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail. 2007; 9:1146- 1155
9. Iacobellis G, Cipriani R, Gabriele A, Di Mario U, Morano S. High circulating vascular endothelial growth factor (VEGF) is related to a better systolic function indiabetic hypertensive patients. Cytokine. 2004; 27:25-30.
10. Jabeen R, Saleemuddin M, Petersen J, Mohammad A, Inactivation and modification of superoxide dismutase by glyoxal: prevention by antibodies. Biochimie. 2007; 3: 311-8.
11. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophy. 1978: 21; 130-132.
12. Kakkar R, Kalra J, Mantha SV, Prasad K. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem. 1995; 151:113-119.
13. Kalim MD, Bhattacharyya D, Banerjee A, Chattopadhyay S, Oxidative DNA damage preventive activity and antioxidant potential of plants used in Unani system of medicine. BMC Complement Altern Med. 2010; 77.
14. Katiyar SK, Afaq F, Perez A, Mukhtar H, Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis. 2001; 2:287-94.
15. Khullar M, Al-Shudiefat AA, Ludke A, Binepal G, Singal PK, Oxidative stress: a key contributor to diabetic cardiomyopathy. Can J Physiol Pharmacol. 2010; 3:233-40.
16. King J. The dehydrogenase of oxidoreductase-lactate dehydrogenase. In: King JC (Ed). Practical Clinical Enzymology van D Wostrand Company, London. 1965; 83-93
17. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990; 186: 464-78.
18. Lorenzi R, Andrades ME, Bortolin RC, Nagai R, Dal-Pizzol F, Moreira JC. Glycolaldehyde Induces Oxidative Stress in the Heart: A Clue to Diabetic Cardiomyopathy? Cardiovasc Toxicol. 2010; 10: 244-249
19. Maritim AC, Sanders RA, Watkins JB 3rd, Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;1:24-38.
20. Mathew S, Menon PV, Kurup PA. Effect of administration of vitamin A, ascorbic acid and nicotinamide adenine dinucleotide + flavin adenine dinucleotide on severity of myocardial infarction induced by isoproterenol in rats. Indian J Exp Biol. 1985; 23: 500-4.
21. Méndez JD, Xie J, Aguilar-Hernández M, Méndez-Valenzuela V. Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases. Mol Cell Biochem. 2010; 344:185-193
22. Mitic MN, Obradovic MV, Grahovac ZB, Pavlovic AN. Antioxidant capacities and phenolic levels of different varieties of Serbian white wines. Molecules. 2010; 15: 2016-2027
23. Moore TC, Moore JE, Kaji Y, Frizzell N, Usui T, Poulaki V, Campbell IL, Stitt AW, Gardiner TA, Archer DB, Adamis AP. The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci. 2003; 44:4457-64.
24. Niehaus WG, Samuelson B. Formation of MDA from phospholipids arachidonate during microsomal lipid peroxidation. European J Biochem. 1968;6:126-130.
25. Okinaka S, Kumogai H, Ebashi S, Sugita H, Momoi H, Toyokura Y, Fujie Y. Serum creatine phosphokinase activity in progressive muscular dystrophy and neuro muscular diseases. Archives of Neurology. 1961; 4: 520-525.
26. Priscilla DH, Prince PS. Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Chem Biol Interact. 2009; 179:118-24.
27. Rasheed Z, Anbazhagan AN, Akhtar N, Ramamurthy S, Voss FR, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res Ther. 2009;11(3): 1-13.
28. Robinson DJ, Christenson RH. Creatine kinase and its CK-MB isoenzyme: the conventional marker for the diagnosis of acute myocardial infarction. J Emerg Med 1999; 17: 95-104.
29. Serisier S, Leray V, Poudroux W, Magot T, Ouguerram K, Nguyen P. Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs. Br J Nutr. 2008; 99:1208-16.
30. Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr. 2001; 131:1207-10.
31. Shreesh O, Mukesh N, Sachin A. Arya DS. Effect of Isoproterenol on Tissue Defense Enzymes, Hemodynamic and Left Ventricular Contractile Function in Rats. Ind J Clin Biochem. 2010: 25: 357-361.
32. Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972: 47: 389-394.
33. Soro-Paavonen A, Zhang WZ, Venardos K, Coughlan MT, Harris E, Tong DC, Brasacchio D, Paavonen K, Chin-Dusting J, Cooper ME, Kaye D, Thomas MC, Forbes JM. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens. 2010 28:780-8.
34. Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, Thomas MC, O'Brien RC, Bierhaus A, Cooper ME, Forbes JM, Coughlan MT. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol. 2010; 298: 763-770
35. Thomas MC, Tikellis C, Burns WM, Bialkowski K, Cao Z, Coughlan MT, Jandeleit-Dahm K, Cooper ME, Forbes JM. Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol. 2005; 16:2976-84.
36. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39: 44-84.